Market Performance - Wall Street experienced a mixed performance last week, with a slump in the middle driven by fears of an AI bubble and doubts over AI investments' substitutability, followed by a strong finish due to Federal Reserve Chair Jerome Powell's hints at a possible September rate cut [1][2] - On August 22, 2025, Wall Street rallied sharply after Powell suggested interest rates could be lowered soon, indicating a shift in the economic outlook that may warrant a change in monetary policy [2][3] - Traders' expectations for a September rate cut rose significantly, with the probability increasing to 91.5% by Friday afternoon, compared to 70% earlier that day and 85% a week prior, leading to a drop in treasury yields and a rise in stock prices [4] Index Performance - The Dow Jones Industrial Average increased by 1.9% to a record high on August 22, 2025, while the S&P 500 rose by 1.5% and the Nasdaq Composite gained 1.9%. Overall, the S&P 500 gained 0.3% last week, the Dow Jones added over 1.5%, and the Nasdaq lost 0.6% [5] ETF Highlights - KraneShares SSE Star Market 50 Index ETF (KSTR) rose by 12.8% last week, focusing on the 50 largest companies on the SSE Science and Technology Innovation Board [7] - AdvisorShares Pure Cannabis ETF (YOLO) increased by 12.5%, benefiting from potential reclassification of marijuana by President Trump [8] - ARK 21Shares Active Ethereum Futures Strategy ETF (ARKZ) gained 11.3%, with Ethereum leading digital asset gains [9] - Global X MSCI China Consumer Discretionary ETF (CHIQ) rose by 6.4%, driven by steady performance in Chinese e-commerce stocks and significant gains in auto stocks like NIO, which surged by 29% [10] - VanEck ChiNext ETF (CNXT) increased by 5.1%, attracting attention due to a sustained recovery in Chinese stocks and capital inflows [12]

Valkea Resources Commences Fall Exploration Program at the Paana Project and Appoints Exploration Manager in FinlandAugust 26, 2025 7:30 AM EDT | Source: Valkea ResourcesVancouver, British Columbia--(Newsfile Corp. - August 26, 2025) - Valkea Resources Corp. (TSXV: OZ) (the "Company" or "Valkea") is pleased to announce that it has commenced its multidisciplinary exploration program across its 100% owned Paana Project, northern Finland. Diamond drilling at Paana will first focus on disseminated ...

Data from BriaCell and the US National Cancer Institute (NCI) support the cancer cell killing potential of BriaCell’s Bria-OTS+ platformBria-OTS+, a novel personalized, off-the-shelf, semi-allogeneic cellular immunotherapy may address urgent unmet medical needs for patients with cancer This study was conducted in collaboration with the NCI PHILADELPHIA and VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “C ...

Core Viewpoint - Valens Semiconductor has appointed Igal Rotem to its Board of Directors, replacing Michael Linse, to enhance its leadership with his extensive experience in the high-tech sector [1][2][3] Company Overview - Valens Semiconductor (NYSE: VLN) is a leader in high-performance connectivity, providing technology that transforms digital experiences globally [4] - The company's chipsets are integrated into various devices, supporting advanced audio-video installations, next-generation videoconferencing, and the development of ADAS and autonomous driving technologies [4] - Valens is known for setting industry standards, including HDBaseT® and MIPI A-PHY [4] Leadership Changes - Igal Rotem's appointment is effective immediately as of August 25, 2025, following a Board meeting [3] - His background includes serving as Chairman of Shift4 EU Bank and leading Finaro to become a global leader in digital acquiring and payment processing solutions [2] - Rotem's experience in scaling businesses and driving strategic growth is expected to be instrumental for Valens as it expands its technology leadership [2]

NervGen Pharma Reports Second Quarter Financial Results and Provides Letter to ShareholdersAugust 26, 2025 7:30 AM EDT | Source: NervGen Pharma Corp.Announced unprecedented Phase 1b/2a topline results in chronic spinal cord injury NVG-291 is the first pharmacologic candidate to demonstrate statistically significant improvement in corticospinal connectivity with clinically meaningful functional gainsOngoing comprehensive analysis of NVG-291's efficacy profile will support upcoming regulatory di ...

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today reported a peer-reviewed publication in the journal iScience, ascertaining the precise autophagy mechanism of ...

WOODS CROSS, Utah, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sky Quarry Inc. (NASDAQ: SKYQ) ("Sky Quarry" or "the Company"), an integrated energy solutions company committed to revolutionizing the waste asphalt shingle recycling industry, today announced that it will host a live investor webinar on Friday, August 29 at 12:00 p.m. PDT / 3:00 p.m. EDT. The webinar will provide an introductory look at how digital treasury strategies could play a role in Sky Quarry’s long-term growth. Marcus Laun, President and Interim ...

LONDON, Aug. 26, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on immune response detection and diagnostics, today announced it has signed a Research Services Agreement ("RSA") with Emory University's Center for the Advancement of Diagnostics for a Just Society ("ADJUST Center") to conduct clinical studies of ViraxImmune™. These studies will focus on immune profiling in individuals with post-viral syndromes, beginning ...

Northern Graphite Secures Federal Support to Extend the Life of Lac des Iles MineAugust 26, 2025 7:30 AM EDT | Source: Northern Graphite CorporationUp to $6.225 million, interest-free repayable contribution will assist in financing continued production at North America's only operating graphite mineFunding supports Canada's critical minerals strategy and Northern's plans to boost domestic supplyOttawa, Ontario--(Newsfile Corp. - August 26, 2025) - Northern Graphite Corporation (TSXV: NGC) (OTC ...

CELEBRATION, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will participate in the following September events: Cantor Global Healthcare Conference on Wednesday, Sept. 3, 2025, at 11:30 a.m. ET.H.C. Wainwright 27th Annual Global Investment Conference on Monday, Sept. 8, 2025, at 10:00 a.m. ...